Study to Evaluate Sodium Stibogluconate With Interferon Alpha-2b

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01479309
Recruitment Status : Withdrawn (Pharmaceutical sponsor terminated study.)
First Posted : November 24, 2011
Last Update Posted : November 24, 2011
VioQuest Pharmaceuticals
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : February 2010
  Actual Study Completion Date : February 2010